Studies Currently Recruiting
Frailty Prevention
The overall goal of this project is to determine whether metformin treatment prevents or reduces frailty in older adults who have pre-diabetes.
Immune MET
Our research team is conducting a study to examine how a medication can improve the immune system in older adults and if it can improve vaccine response to the pneumonia vaccine.
STARR
The purpose of the South Texas Aging Registry and Repository (STARR) is to collect health information, blood and specimens to store for future research purposes. We want to learn more about how to improve the health and quality of life of older adults. We are also working to learn how genes affect the way a person ages or how aging influences genes and the cells they affect.
Exercise Science/MoTrPAC
You know that exercise is good for your health, but have you ever wondered why? We’re looking for men and women who are 18 years of age and older to participate in our MoTrPAC research study.
SToMP-AD
This study will evaluate the combination of two medications to see if it has effects on individuals with early Alzheimer’s disease.
Women’s Health and Aging
We invite you to complete an online survey on women’s health and aging! Our goal is to learn more about how best to promote healthy aging among women by looking at a number of factors related to women’s health and aging, including social, lifestyle, and environmental factors.
SGLT2i
Looking for participants who are 60 and older, overweight, and have borderline diabetes. We want to evaluate the effect of the FDA approved medication dapagliflozin on the reduction of cellular damage, pro-inflammatory cells of aging and other known markers of biological aging.
PREVENTABLE
The purpose of this study is to learn if taking a statin could help older adults live well for longer by preventing dementia, disability or heart disease.
ART-AD
This study will evaluate if the medication 3TC will effectively prevent decline and loss of function in the nervous system of adults with early Alzheimer’s Disease.